| Announce Date | 01/30/2026 |
| EPS Normalized Actual | $-0.48 (Miss by $-1.86) |
| EPS GAAP Actual | $-0.48 (Miss by $-1.86) |
| Revenue Actual | $7.20304B |
| Revenue Surprise | Beat by $7203.04M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $8.367140643B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Dec 2026 | 5.73 | 6.05 | 5.73 | 5.73 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.48 | -0.28807 | 7.20304B | -3.11% | 2722.06M |
| FQ3 2025 (Sep 2025) | -0.31 | -0.12016 | 6.919B | -33.43% | 2437.92M |
| FQ2 2025 (Jun 2025) | 0.14 | 0.3316 | 6.80532B | -75.5% | 2282.64M |
| FQ1 2025 (Mar 2025) | 0.38 | 0.59183 | 6.749B | -77.23% | 2282.78M |
| FQ4 2024 (Dec 2024) | -0.69 | -0.83985 | 7.427B | -85.48% | 2994.53M |
| FQ3 2024 (Sep 2024) | 1.39 | 1.40998028 | 9.232B | -55.97% | -6892.08M |
| FQ2 2024 (Jun 2024) | -0.1 | -1.44259 | 11.9435B | -13.08% | -15068.5M |
| FQ1 2024 (Mar 2024) | 0.078 | 0.078 | 11.9613B | 100% | 11961.3M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
8.367140643B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0 | INF | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | INF | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 9.25B | 22.17 | 9.25B | 9.25B | 1 |
| FQ3 2026 (Sep 2026) | 8.8B | 21.39 | 8.8B | 8.8B | 1 |
| FQ2 2026 (Jun 2026) | 8.05B | 15.44 | 8.05B | 8.05B | 1 |
| FQ1 2026 (Mar 2026) | 8.37B | 19.34 | 8.37B | 8.37B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.19193 | -0.48 | -0.28807 | 60.01% |
| FQ3 2025 (Sep 2025) | -0.18984 | -0.31 | -0.12016 | 38.76% |
| FQ2 2025 (Jun 2025) | -0.1916 | 0.14 | 0.3316 | 236.86% |
| FQ1 2025 (Mar 2025) | -0.21183 | 0.38 | 0.59183 | 155.74% |
| FQ4 2024 (Dec 2024) | 0.14985 | -0.69 | -0.83985 | 121.72% |
| FQ3 2024 (Sep 2024) | -0.01998028 | 1.39 | 1.40998028 | 101.44% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.1 | -1.44259 | 1442.59% |
| FQ1 2024 (Mar 2024) | 0.078 | 0.078 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $4.48B | $7.2B | $2722.06M | 37.79% |
| FQ3 2025 (Sep 2025) | $4.48B | $6.92B | $2437.92M | 35.24% |
| FQ2 2025 (Jun 2025) | $4.52B | $6.81B | $2282.64M | 33.54% |
| FQ1 2025 (Mar 2025) | $4.47B | $6.75B | $2282.78M | 33.82% |
| FQ4 2024 (Dec 2024) | $4.43B | $7.43B | $2994.53M | 40.32% |
| FQ3 2024 (Sep 2024) | $16.12B | $9.23B | $-6892.08M | -74.65% |
| FQ2 2024 (Jun 2024) | $27.01B | $11.94B | $-15068.5M | -126.16% |
| FQ1 2024 (Mar 2024) | $0B | $11.96B | $11961.3M | 100% |